Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery

Renato D Lopes1, Rajendra H Mehta, Gail E Hafley

  • 1Duke Clinical Research Institute, Duke University Medical Center, DUMC Box 3850, Durham, NC 27705, USA.

Circulation
|January 13, 2012
PubMed

Insights

Vein graft failure is common after coronary artery bypass graft surgery. While it increases the risk of repeat revascularization, it does not significantly impact death or myocardial infarction rates.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Biology
  • Clinical Outcomes Research

Background:

  • Vein graft failure (VGF) is a frequent complication following coronary artery bypass graft (CABG) surgery.
  • The long-term clinical impact of VGF remains incompletely understood.
  • This study investigates the association between VGF and subsequent patient outcomes.

Purpose of the Study:

  • To determine the relationship between vein graft failure (VGF) and long-term clinical outcomes after coronary artery bypass graft (CABG) surgery.
  • To assess the impact of VGF on rates of death, myocardial infarction, and repeat revascularization.

Main Methods:

  • Retrospective analysis of 1829 patients from the PREVENT IV trial database.
  • Coronary angiography assessed VGF 12–18 months post-CABG surgery.
  • Clinical outcomes (death, myocardial infarction, repeat revascularization) were tracked for 4 years post-angiography.

Main Results:

  • Vein graft failure (VGF) was observed in 43% of patients (787/1829).
  • Patients with any VGF had a significantly higher incidence of the composite outcome of death, myocardial infarction, or repeat revascularization (aHR, 1.58; P=0.008).
  • This increased risk was primarily driven by more frequent repeat revascularization, with no significant differences in death or myocardial infarction rates.

Conclusions:

  • Vein graft failure (VGF) is prevalent after coronary artery bypass graft (CABG) surgery.
  • VGF is associated with an increased need for repeat revascularization but not with increased mortality or myocardial infarction.
  • Further research is warranted to develop strategies for mitigating VGF and improving long-term outcomes in CABG patients.
Abstract